Dissenting Statement of Commissioner Maureen K. Ohlhausen In the Matter of Endo Pharmaceuticals Inc.
Date
By
Maureen K. Ohlhausen, Former Commissioner
Matter Number
1410004
Displaying 2381 - 2400 of 4770
Bedford Laboratories/Hikma Pharmaceuticals, In the Matter of
Generic drug marketer Hikma Pharmaceuticals PLC agreed to divest its rights and interests in five generic injectable pharmaceuticals to settle charges that its $5 million acquisition of the rights to various drug products and related assets from Ben Venue Laboratories, Inc. would likely be anticompetitive. According to the complaint, without a remedy, Hikma’s purchase of certain generic injectables would likely harm future competition in the U.S. markets for (1) Acyclovir sodium injection: an antiviral drug used to treat chicken pox, herpes, and other related infections, (2) Diltiazem hydrochloride injection: a calcium channel blocker and antihypertensive used to treat hypertension, angina, and arrhythmias, (3) Famotidine injection: a treatment for ulcers and gastroesophageal reflux disease, (4) Prochlorperazine edisylate injection: an antipsychotic drug used to treat schizophrenia and nausea, and (5) Valproate sodium injection: a treatment for epilepsy, seizures, bipolar disorder, anxiety, and migraine headaches. Hikma is required to divest the five generic injectable drug assets to Amphastar Pharmaceuticals, Inc., a California-based specialty pharmaceutical company that sells generic injectable and inhalation products.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0044
FTC Staff Comment: Alaska Legislature Should Consider Potential Benefits to Consumers of Expanding Access to Telehealth Services
Date
Federal Trade Commission staff submitted a comment, as public testimony, to the Alaska legislature on proposed legislation that would allow licensed Alaska physicians located out-of-state to provide...
FTC Staff Comment: Kentucky Legislature Should Consider Potential Benefits to Consumers of Enhanced Competition Among Denture Providers
Date
Federal Trade Commission staff submitted a comment on the competitive implications of proposed legislation that would license and regulate denturists within Kentucky. Denturists are trained to make...
1603004 Informal Interpretation
Date
Rule
Item 4(c), 4(d)
MOV files are not responsive to 4(c).
File
Original Image
(33.04 KB)
1603005 Informal Interpretation
Date
Rule
Items 3 and 4(b)
Do not need to translate documents reponsive to Items 3 or 4. If the agreement is in a foreign language, provide a thorough description of the transaction in Item 3(a). If the annual report is in a...
File
Original Image
(38.77 KB)
1603003 Informal Interpretation
Date
Rule
801.2(e)
Analyze potential backside filing requirements (801.2(e)) based on where the entities stand before the main transaction.
File
Original Image
(135.44 KB)
FTC Commissioner Julie Brill to Resign
Date
Julie Brill, who has served as a Commissioner of the Federal Trade Commission since April 2010, will resign her position at the end of this month. “Commissioner Brill has been an unwavering advocate...
1603002 Informal Interpretation
Date
Rule
801.2(g)
Nothing reportable. A retaining commercial rights to the compound as a single agent in the same indication makes the license to B non-exclusive.
File
Original Image
(116.12 KB)
Statement of FTC Chairwoman Edith Ramirez on the U.S. Supreme Court's Decision in McWane Inc. v. FTC
Date
Federal Trade Commission Chairwoman Edith Ramirez issued the following statement regarding the Supreme Court’s denial of certiorari in McWane Inc. v. FTC. The Court declined to review an April 2015...
FTC Approves Final Order Preserving Competition Among Outpatient Dialysis Clinics in Laredo, Texas
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that national kidney-dialysis chain U.S. Renal Care, Inc.’s $640 million acquisition of...
Rangers Renal Holding, LP; US Renal Care, Inc.; Dialysis Parent, LLC and Dialysis HoldCo, LLC, In the Matter of
To settle charges that its acquisition of DSI Renal would substantially lessen competition for outpatient dialysis services in Laredo, Texas, U.S. Renal agreed to divest three clinics to Satellite Healthcare, Inc.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0215
Public Statement
INNOVATE2016: The role of the FTC and federal regulators in Silicon Valley (Video)
Date
FTC Amicus Brief Urges Appeals Court to Correct Legal Errors in District Court’s Antitrust Analysis of Reverse-Payment Agreement
Date
The Federal Trade Commission filed an amicus brief with the U.S. Court of Appeals for the Third Circuit urging the court to correct four legal errors in a district court’s antitrust analysis of an...
In re Wellbutrin Antitrust Litigation
Date
Citation Number
15-3559, 15-3591, 15-3681, 15-3682
Federal Court
U.S. Circuit Court of Appeals for the Third Circuit
Brief of the Federal Trade Commission arguing that the district court committed multiple legal errors that should be corrected on appeal. The district court erroneously concluded that a reverse...
File
Text of the Amicus Brief
(266.47 KB)
FTC Staff: Proposed Health Care Legislation in West Virginia Would Likely Be Anticompetitive and Harm Consumers
Date
Federal Trade Commission staff submitted written comments on the competitive impact of provisions in proposed legislation in West Virginia that would provide for “cooperative agreements” between...
Prepared Statement of the Federal Trade Commission On "Oversight of the Enforcement of the Antitrust Laws"
Date
By
Edith Ramirez, Former Chairwoman
Matter Number
P859910
File
Text of the Commission Testimony
(95.73 KB)
FTC Chairwoman Ramirez Testifies Before Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights
Date
Testifying on behalf of the Federal Trade Commission before the U.S. Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, Chairwoman Edith Ramirez outlined how effective...
1603001 Informal Interpretation
Date
Rule
801.10, 801.30
If multiple open market purchases are made on the same day, the buyer need not (but may) revalue its holdings more than once daily.
File
Original Image
(69.09 KB)
Displaying 2381 - 2400 of 4770